Exocure Sweden AB — GU Ventures

There is a significant unmet medical need to improve targeting if treatment with a variety of medications for several disease, including cancer. Exosomes can be loaded with such drugs and enable more efficient treatment, reducing dose and thereby unwanted adverse events. Exocure’s exosomes are the most potent so far developed, as they synergize with the cargo to achieve higher efficacy.